Publications

Export 138596 results:
Sort by: Author Title Type [ Year  (Desc)]
1917
توفيق, سعيد (1917).  تأويل الفن والدين.
1916
SWH, H. (1916).  Cerebellar nuclei and connections in man.. Anatomy Physiology Biochem Int J (APBIJ). 1(1), 555552.apbij.ms_.id_.555552-2.pdf
[Anonymous] (1916).  Cerebellar nuclei and connections in man.. Anatomy Physiology Biochem Int J (APBIJ). 1(1), 555552.apbij.ms_.id_.555552-2.pdf
1915
undefined (1915).  Fetuin A. Transplantation proceedings. 47, 2703-2706.transplantation_proceedings_fetuin_a.pdf
1900
MA, E. G., & MMH E. A. (1900).  On the Determination of Optimal Model Order for GMM-Based Text-Independent Speaker Identification. EURASIP Journal on Advances in Signal Processing. 2004(8), 1078-1087. Abstract

Gaussian mixture models (GMMs) are recently employed to provide a robust technique for speaker identification. The determination of the appropriate number of Gaussian components in amodel for adequate speaker representation is a crucial but difficult problem. This number is in fact speaker dependent. Therefore, assuming a fixed number of Gaussian components for all speakers is not justified. In this paper, we develop a procedure for roughly estimating the maximum possible model order above which the estimation of model parameters becomes unreliable. In addition, a theoretical measure, namely, a goodness of fit (GOF) measure is derived and utilized in estimating the number of Gaussian components needed to characterize different speakers. The estimation is carried out by exploiting the distribution of the training data for each speaker. Experimental results indicate that the proposed technique provides results comparable to other well-known model selection criteria like the minimum description length (MDL) and the Akaike information criterion (AIC).

MA, E. G., & MMH E. A. (1900).  On the Determination of Optimal Model Order for GMM-Based Text-Independent Speaker Identification. EURASIP Journal on Advances in Signal Processing. 2004(8),  Abstract
n/a
1435
1215
Miller, S. A., D. D. D., & Polesky H. F. (1215).  (1988). A simple salting out procedure for extracting DNA from human nucleated cells.research,. Nucleic acids. 16, Abstract
n/a
Miller, S. A., D. D. D., & Polesky H. F. (1215).  (1988). A simple salting out procedure for extracting DNA from human nucleated cells.research,. Nucleic acids. 16, Abstract
n/a
1099
1015
296
Kamal, H. (296).  A Century of Egyptian Women's Demands: The Four Waves of the Egyptian Feminist Movement. Advances in Gender Research. 21, 3-22.
217
Essa, E. - S. M. M., Aboelela M. A. S., & Hassan M. A. M. (217).  Application of Fractional Order Controllers on Experimental and Simulation Model of Hydraulic Servo System. Fractional Order Control and Synchronization of Chaotic Systems.
214
210
Issa, Y. M., El-Hawary W. F., Youssef A. F. A., & Senosy A. R. (210).  Spectrophotometric Determination of Sildenafil Citrate in Pure Form and in Pharmaceutical Formulation Using Some Chromotropic Acid Azo Dyes. Spectrochim. Acta Part A. 75(4), 1297-1303.
207
Elhariri1, M., Aleslamboly Y. S., Elshate M. A., Elhelw R., & Refai M. K. (207).  Rapid Salmonella Detection in Different Food Detection in Different Food Detection in Different Food Detection in Different Food. BIOSCIENCE RESEARCH . 14(4),  : 1005-1010.salmonella_paper.pdf
204
202
Chapman, J. B., Pohlmann K., Pohll G., Hassan A. E., Sanders P., Sanchez M., et al. (202).  Remediation of the Faultless Underground Nuclear Test: Moving Forward in the Face of Model Uncertainty. Waste Management Conference, WM'02, Session 28A, paper 456.
201
Alkady, O. H., Metwally H. G., Hany A Abdelsalam, Hassan A. M., Osama H Abdel-salam, & Saleh A. A. (201).  Comparison Treatment of Vitiligo by Co-culture of Melanocytes Derived from Hair Follicle with Adipose-Derived Stem Cells with and without NB-UVB. Journal of Pigmentary Disorders . 4(1), 
Hassanein, S. S., Ibrahim S. A. A., & Abdel-Mawgood A. L. (201).  Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands . Int J Mol Sci . 22(22), 12496.
89
Ahmed, H. H.;, Taha; N., El-Nahla; A. M., & S.A.Essawy (89).  Effect of modulating prolactin level by neurotransmitters and exogenous prolactin on testosterone level in male rats.. . ESARF and Fac. Vet. Med., Alex Univ., First annual Congreaa, Edfina.. 24-26.
23
21
El-Ansary, O., & Al-Gazzar H. (21).  Working capital and financial performance in MENA region. Journal of Humanities and Applied Social Sciences.
5
1
Seleem, H., ElNahas T., & Mostafa M. (1).  1. THE EFFICACY AND TOXICITY OF OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN AS ADJUVANT TREATMENT IN PATIENTS WITH COLON CANCER. Abstract

Background: Although surgical resection is still the only curative maneuver in the treatment of colon cancer,
yet efforts have proved that systemic chemotherapy in the adjuvant setting improves the curative rate for those
patients with localized colon cancer. The combination of 5-fluorouracil (5-Fu) and leucovorin (LV) was the
reference treatment. However the advantage of infusional 5-Fu/LV with oxaliplatin (FolFox-4) as adjuvant
treatment for high risk colon cancer patients may change the paradigm soon. In this study we presented our
treatment results for patients with colon cancer treated with FolFox- 4 regimen as adjuvant treatment at Kasr Al
Aini Hospital.
Patients and Methods: We enrolled 55 patients who had undergone curative resection for sage II and III colon
cancer to receive FolFox-4 regimen for six months. The primary end point was disease –free survival
Results: Fifty five patients were included in this study. At the time of analysis (median follow up 18 months)
9 patients (16%) had disease relapse or metastasis. At 2.5 years DFS rates and OAS rates were 75% and 80%,
respectively. The treatment was generally well tolerated with most common grade 1 treatment-related adverse
event being peripheral neuropathy and hematological toxicity.
Conclusion: It is now acceptable to consider combination chemotherapy with FolFox -4 as adjuvant treatment
for high risk colon cancer patients after curative surgery at Kasr El Ainy center of Radiation Oncology and
nuclear medicine

0